The upregulation of Trem2 expression has been consistently reported in multiple inflammatory diseases, including nonalcoholic steatohepatitis,[85] atherosclerosis,[86] and obesity.[87] However, the biological function of Trem2 in vascular diseases remains controversial. Here, TREM2 is linked to obesity due to melanocortin 4 receptor deficiency.